Manufacturing for your patients

Peptide API manufacturer

Delivering high‑quality Peptide drug substances with over 50 years of experience, refined process development, and efficient GMP large‑scale production to support your path from discovery to commercial supply.

Hero_subpage_img
Pattern
Pattern

4

GMP sites

Grams to tons

Manufacturing scale

2/3

of approved Peptide API produced

Exclusive vs. Generic APIs: Tailored strategies for each model

We deliver commercial‑scale Peptide APIs under two fundamentally different business models. Each model serves your needs, and our organization is structured to excel in both.

Exclusive Single‑Customer APIs (NCEs): Tailored partnerships for innovative, proprietary molecules

These projects involve new chemical entities (NCEs) that are protected by intellectual property and developed for a single pharmaceutical partner. Bachem acts as a long‑term strategic manufacturer, supporting the molecule from early development through global commercial supply.

Key characteristics

  • Exclusive supply relationship with one customer
  • Highly customized processes developed specifically for the molecule
  • Close scientific collaboration and integrated project teams
  • Flexible scaling from clinical to commercial volumes
  • Extensive CMC and regulatory support throughout the lifecycle
  • High confidentiality and IP protection
  • Continuous process optimization to support long‑term commercial success
  • Cost‑competitive manufacturing for exclusive and generic APIs
This model is ideal for innovators bringing first‑in‑class or best‑in‑class therapies to market.

image_text_img
Pattern Pattern
image_text_img

Generic / Multi‑customer APIs: High‑quality, cost‑efficient APIs for competitive global markets

Generic APIs are produced for multiple customers once patents have expired. Bachem provides robust, validated, and regulatory‑ready APIs that enable fast market entry and reliable long‑term supply.

Key characteristics

  • Non‑exclusive supply to many customers worldwide
  • Established, validated manufacturing processes
  • Comprehensive regulatory documentation (DMFs, CEPs, global filings)
  • Large‑scale, cost‑efficient production
  • Consistent quality and batch‑to‑batch reliability
  • Secure supply chain, including in‑house production of key starting materials
  • Rapid onboarding for new customers
This model supports companies competing in global generic markets where reliability, quality, and cost efficiency are critical.
Pattern

Generic API product catalog

API CEP / DMF Application Location
Atosiban DMF Reproductive Medicine CH
Buserelin DMF Oncology, Reproductive Medicine CH
Carbidopa CEP / DMF Epilepsy and Parkinson‘s Disease CH
Etomidate CEP / DMF Sedatives and Anesthetics CH
Glucagon DMF Diabetes Mellitus CH
Gonadorelin Acetate CEP / DMF Oncology, Reproductive Medicine CH
Goserelin Acetate CEP / DMF Oncology, Reproductive Medicine CH
Leuprolide Acetate CEP / DMF Oncology CH
Octreotide Acetate CEP / DMF Oncology CH
Propofol CEP / DMF Sedatives and Anesthetics CH
Somatostatin CEP / DMF Gastritis CH
Teriparatide Acetate / pTH (1-34) (human) DMF Osteoporosis USA
Tetracosactide DMF Oncology, Diagnostics CH
Triptorelin Acetate DMF Oncology, Reproductive Medicine CH
Triptorelin Pamoate DMF Oncology, Reproductive Medicine CH

Why choose Bachem

Proven leadership

A globally trusted manufacturer of Peptide APIs driving a high‑value share of the world’s commercial Peptide API supply.

End-to-end expertise

Support from early development through commercial supply for both NCEs and generics.

Scalable manufacturing

Flexible production from grams to tons with consistent, GMP-compliant quality.

Regulatory excellence

Comprehensive documentation and global regulatory support backed by FDA, EMA, and Swissmedic as well as PMDA, CDE, and ANVISA inspections.

Secure supply chain

In-house production of key starting materials combined with strategic dual-sourcing and a non-China supply approach ensures maximum reliability, continuity, and risk reduction.

Innovation-driven approach

Cutting-edge technologies and continuous process optimization for efficient, cost-effective API production.

Our sites for commercial Peptide API manufacturing

Bubendorf

Bachem’s Headquarters is our largest GMP hub for Peptide and Oligonucleotide production, advancing development and global supply.

Bachem Torrance Peptide Manufacturing Site

Torrance

Our cGMP site at Torrance focuses on Peptide NCEs, offering SPPS development, small‑to‑medium‑scale manufacturing, and comprehensive API analytics.

Vista

The Vista cGMP site in the US is a medium-to-large-volume manufacturing facility for commercial API, Peptide NCEs and intermediates.

Vionnaz

A high‑capacity GMP site for small molecules and Peptides, combining advanced chemistry and strong global API supply.

Shaping the future

Driving commercial Peptide drugs together

Rely on our years of experience in manufacturing Peptide APIs for your next commercial drug venture.